SeQuent Scientific share price
You have to be logged in to add this to Watchlist.- ₹193.00(-2.60%)January 12, 2026 15:29:56 PM IST
- NSE
- BSE
- Vol : 769.80 K (NSE + BSE)Last 20 day avg : 681.13 K
SeQuent Scientific is trading -2.60% lower at Rs 193.00 as compared to its last closing price. SeQuent Scientific has been trading in the price range of 198.20 & 189.05. SeQuent Scientific has given -4.78% in this year & -5.66% in the last 5 days. SeQuent Scientific has TTM P/E ratio 110.75 as compared to the sector P/E of 23.01.The company posted a net profit of 14.74 Crores in its last quarter.Listed peers of SeQuent Scientific include Divi's Laboratories (-1.89%), Sun Pharmaceutical Industries (0.26%), Dr Reddy's Laboratories (0.48%).The Mutual Fund holding in SeQuent Scientific was at 5.85% in 16 Dec 2025. The MF holding has increased from the last quarter. The FII holding in SeQuent Scientific was at 3.15% in 16 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 12, 2026, 06:38 PM UTC
- BetaHigh volatility1.48Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.68The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values7.06The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG RatioIndicates undervaluation-6.16The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,491.90 | -1.89 | 1,72,403.39 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Neutral | 1,734.40 | 0.26 | 4,14,477.34 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bearish | 1,215.25 | 0.48 | 1,01,089.38 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 3,948.25 | -0.37 | 1,33,650.02 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,466.05 | -0.01 | 1,18,366.87 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-14 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE807F01027
- BSE Code512529
- NSE CodeSEQUENT
SeQuent Scientific is trading at 193.00 as on Mon Jan 12 2026 09:59:56. This is -2.60% lower as compared to its previous closing price of 198.15.
The market capitalization of SeQuent Scientific is 4904.37 Cr as on Mon Jan 12 2026 09:59:56.
The 52 wk high for SeQuent Scientific is 260.30 whereas the 52 wk low is 111.00
SeQuent Scientific can be analyzed on the following key metrics -
- TTM P/E: 110.75
- Sector P/E: 23.01
- Dividend Yield: 0.00%
- D/E ratio: 0.61
SeQuent Scientific reported a net profit of 21.88 Cr in 2025.
The Mutual Fund Shareholding was 5.85% at the end of 16 Dec 2025.